|
+
PDF
Chat
|
A Proposed Confidence Ellipse Approach for Benefit-Risk Assessment in Clinical Trials
|
2024
|
Y. Zhang
Xiaofang Zhang
Peijing Wang
Yangfeng Wu
Shein‐Chung Chow
|
|
+
|
Statistical Analysis for Rating Scale in Clinical Trials
|
2024
|
Mengyao Shi
Shein‐Chung Chow
|
|
+
|
Utility of real-world evidence in biosimilar development
|
2024
|
Ramin B. Arani
Jessie Wang
Dong Pang
Samriddhi Buxy Sinha
Martina Uttenreuther‐Fischer
Shein‐Chung Chow
|
|
+
|
The use of real-world data for clinical investigation of effectiveness in drug development
|
2024
|
Peijin Wang
Shein‐Chung Chow
|
|
+
|
Analysis of innovative two-stage seamless adaptive design with different endpoints and population shift
|
2024
|
Weijia Mai
Shein‐Chung Chow
|
|
+
|
On the use of RWD in support of regulatory submission in drug development
|
2024
|
Shein‐Chung Chow
Peijin Wang
|
|
+
PDF
Chat
|
Statistical Analysis for Rating Scale in Clinical Trials
|
2024
|
Mengyao Shi
Shein‐Chung Chow
|
|
+
PDF
Chat
|
Evidence of pre-approval clinical trial supporting the granted conditional approval for novel cancer drugs in China between 2015 and 2022
|
2023
|
Xingxian Luo
Xin Du
Lin Huang
Qixiang Guo
Xufeng Lv
Cen Wang
Haopeng Liu
Yue Zhou
Xuecai Xue
Zhuangqi Li
|
|
+
|
Statistical tests for detecting reference product change in biosimilar studies
|
2023
|
Jiayin Zheng
Peijin Wang
Yixin Wang
Shein‐Chung Chow
|
|
+
|
Statistical Evaluation of Responder Analysis in Stem Cell Clinical Trials
|
2023
|
Jiajun Liu
Emily Poehlein
Shein‐Chung Chow
|
|
+
|
Evaluation of clinical trial designs for novel anticancer drugs in China: A cohort study of drugs approved between 2015 and 2021
|
2023
|
Xingxian Luo
Qixiang Guo
Xin Du
Lin Huang
Shein‐Chung Chow
Yang Yue
|
|
+
|
A Proposal for Post Hoc Subgroup Analysis in Support of Regulatory Submission
|
2022
|
Jiajun Liu
Shein‐Chung Chow
|
|
+
|
Introduction
|
2022
|
Wei Zhang
Fangrong Yan
Feng Chen
Shein‐Chung Chow
|
|
+
|
Advanced Statistics in Regulatory Critical Clinical Initiatives
|
2022
|
Wei Zhang
Fangrong Yan
Feng Chen
Shein‐Chung Chow
|
|
+
|
Statistical Methods for Assessment of Biosimilars
|
2022
|
Yafei Zhang
Vivian Gu
Xiuyu Julie Cong
Shein‐Chung Chow
|
|
+
|
Rare Diseases Drug Development
|
2022
|
Shein‐Chung Chow
Shutian Zhang
Wei Zhang
|
|
+
PDF
Chat
|
The impact of block size on treatment imbalance and blinding integrity in randomized clinical trials
|
2022
|
Peijin Wang
Shein‐Chung Chow
|
|
+
PDF
Chat
|
Statistical evaluation of absolute change versus responder analysis in clinical trials
|
2022
|
Peijin Wang
Sarah B. Peskoe
Rebecca Byrd
Patrick J. Smith
Rachel Breslin
Shein‐Chung Chow
|
|
+
|
Innovative Design and Analysis for PK/PD Biosimilar Bridging Studies with Multiple References
|
2021
|
Fuyu Song
Xin Xiao Zheng
Yujia Wang
Shein‐Chung Chow
Hongqiang Sun
|
|
+
PDF
Chat
|
Review of current controversial issues in clinical trials
|
2021
|
Shein‐Chung Chow
Susan S. Chow
Annpey Pong
|
|
+
|
Innovative Two-Stage Seamless Adaptive Clinical Trial Designs
|
2021
|
Shein‐Chung Chow
Xinyu Zhang
Weijia Mai
|
|
+
|
Sample size re‐estimation in clinical trials
|
2021
|
Peijin Wang
Shein‐Chung Chow
|
|
+
|
PK/PD Bridging Studies
|
2021
|
Fuyu Song
Xin Zheng
Shein‐Chung Chow
|
|
+
|
Detecting Reference Product Change in Biosimilar Studies
|
2021
|
Jiayin Zheng
Peijin Wang
Yixin Wang
Shein‐Chung Chow
|
|
+
|
Two One-Sided Tests Versus Confidence Interval Approach
|
2021
|
Jingyu Julia Luan
Weijia Mai
Shein‐Chung Chow
|
|
+
|
Biosimilar Product Development
|
2021
|
Sang Joon Lee
Shein‐Chung Chow
|
|
+
|
Modified Quality Range Method for Analytical Similarity Evaluation
|
2021
|
Sung Taek Son
Min Kyung Oh
Min Joo Choo
Shein‐Chung Chow
Sang Joon Lee
|
|
+
|
Sensitivity Analysis for Assessment of Extrapolation
|
2021
|
Junheng Gao
Chenxuan Zang
Ying Lyu
Shein‐Chung Chow
|
|
+
|
Stability Studies
|
2021
|
Mo Liu
Yuqing Liu
Shein‐Chung Chow
|
|
+
|
Non-inferiority/Similarity Margin
|
2021
|
Jingyu Julia Luan
Wenyue Zhuo
Shein‐Chung Chow
|
|
+
|
Quality by Design
|
2021
|
Min Joo Choo
Ji Youn Kim
Shein‐Chung Chow
Sang Joon Lee
|
|
+
|
Equivalence Test with Flexible Margin
|
2021
|
Sang Joon Lee
Minkyung Oh
Shein‐Chung Chow
|
|
+
|
Design and Analysis of Biosimilar Switching Studies
|
2021
|
Shein‐Chung Chow
Sang Joon Lee
|
|
+
|
The use of real-world data/evidence in regulatory submissions
|
2021
|
Fuyu Song
Chenxuan Zang
Xinyi Ma
Sifan Hu
Qiqing Sun
Shein‐Chung Chow
Hongqiang Sun
|
|
+
|
Statistical Considerations for Gene Therapy Rare Disease Clinical Trials
|
2021
|
Chenxuan Zang
Wei Zhang
Shein‐Chung Chow
|
|
+
|
A Time-response Measure to Assess Clinical Equivalence in Rheumatoid Arthritis: an Assessment Using Data From Clinical Trials of Biosimilars
|
2020
|
Michael O’Kelly
Aijing Zhang
Ilya Lipkovich
Guochen Song
Russell Reeve
Bohdana Ratitch
Siying Li
Martha Behnke
Jonathan Kay
Shein‐Chung Chow
|
|
+
|
Innovative Methods for Rare Disease Drug Development
|
2020
|
Shein‐Chung Chow
|
|
+
|
Endpoint Selection in Clinical Trials
|
2020
|
Shein‐Chung Chow
|
|
+
|
Probability of Inconclusiveness
|
2020
|
Shein‐Chung Chow
|
|
+
|
The n-of-1 Trial Design and Its Application
|
2020
|
Shein‐Chung Chow
|
|
+
|
Two-Stage Adaptive Seamless Trial Design
|
2020
|
Shein‐Chung Chow
|
|
+
|
Master Protocol – Platform Trial Design
|
2020
|
Shein‐Chung Chow
|
|
+
PDF
Chat
|
Time to Revisit Endpoint Selection in Clinical Trials
|
2020
|
Shein‐Chung Chow
|
|
+
PDF
Chat
|
Statistical Evaluation of Clinical Trials Under COVID-19 Pandemic
|
2020
|
Shein‐Chung Chow
Wei Zhang
|
|
+
|
Some thoughts on the QR method for analytical similarity evaluation
|
2020
|
Sungtaek Son
Minkyung Oh
Minjoo Choo
Shein‐Chung Chow
Sang Joon Lee
|
|
+
|
Innovative design and analysis for rare disease drug development
|
2020
|
Shein‐Chung Chow
Zhipeng Huang
|
|
+
|
Innovative Statistics in Regulatory Science
|
2019
|
Shein‐Chung Chow
|
|
+
|
Adaptive Trial Design
|
2019
|
Shein‐Chung Chow
|
|
+
|
Hypotheses Testing versus Confidence Interval
|
2019
|
Shein‐Chung Chow
|
|
+
|
Multiplicity
|
2019
|
Shein‐Chung Chow
|
|
+
|
Criteria for dose-finding in two-stage seamless adaptive design
|
2019
|
Jiayin Zheng
Shein‐Chung Chow
|
|
+
|
Innovative Thinking on Endpoint Selection in Clinical Trials
|
2019
|
Shein‐Chung Chow
Zhipeng Huang
|
|
+
|
Simultaneous confidence interval methods for analytical similarity assessment
|
2019
|
Jiayin Zheng
Donglei Yin
Mengdie Yuan
Shein‐Chung Chow
|
|
+
|
Statistical considerations for rare diseases drug development
|
2019
|
Shein‐Chung Chow
Yu‐Wei Chang
|
|
+
|
Demonstrating effectiveness or demonstrating not ineffectiveness – A potential solution for rare disease drug product development?
|
2019
|
Shein‐Chung Chow
Zhipeng Huang
|
|
+
|
Probability monitoring procedures for sample size determination
|
2019
|
Zhipeng Huang
Shein‐Chung Chow
|
|
+
|
The use of 95% CI or 90% CI for drug product development — a controversial issue?
|
2019
|
Shein‐Chung Chow
Jiayin Zheng
|
|
+
|
Design and Analysis of Biosimilar Switching Studies
|
2019
|
Shein‐Chung Chow
Sang Joon Lee
|
|
+
|
Statistics In the Pharmaceutical Industry
|
2019
|
Ronald J. Bosch
C. Ralph Buncher
Shein‐Chung Chow
Satya D. Dubey
J. Y. Tsay
Charles W. Dunnett
P.H. van Ewijk
Roger E. Flora
Paul S. Horn
Irving K. Hwang
|
|
+
|
On Bayesian Analysis and Hypothesis Testing in the Determination of Bioequivalence
|
2019
|
Donald J. Schuirmann
Stella Grosser
Somesh Chattopadhyay
Shein‐Chung Chow
|
|
+
|
Interim analysis of binary outcome data in clinical trials: a comparison of five estimators
|
2019
|
Qing Lu
Shein‐Chung Chow
Siu‐Keung Tse
|
|
+
|
Practical Statistical Issues in Evaluation of Average Bioequivalence
|
2019
|
Shein‐Chung Chow
Mo Liu
|
|
+
|
Sample Size Requirement
|
2018
|
Shein‐Chung Chow
|
|
+
|
Imputation with Item Nonrespondents
|
2018
|
Hansheng Wang
Shein‐Chung Chow
|
|
+
|
Translational medicine: Concepts, Statistical Methods, and Related Issues
|
2018
|
Siu‐Keung Tse
Shein‐Chung Chow
|
|
+
|
Clinical Trial: N -of-1 Design Analysis
|
2018
|
Can Cui
Shein‐Chung Chow
|
|
+
|
Generalizability Probability in Clinical Research
|
2018
|
Shein‐Chung Chow
|
|
+
|
Multi-Regional Clinical Trials: Consistency Test
|
2018
|
Jiayin Zheng
Lisa Ying
Zeng Na
Shein‐Chung Chow
|
|
+
|
Biosimilarity of Follow-On Biologics
|
2018
|
Shein‐Chung Chow
Jen‐pei Liu
|
|
+
|
Drug Interchangeability: Meta-Analysis for Safety Monitoring
|
2018
|
Liu Wenwei
Shein‐Chung Chow
|
|
+
|
Sample Size Calculation: Nonparametrics
|
2018
|
Hansheng Wang
Shein‐Chung Chow
|
|
+
|
In Vitro Testing: Bioequivalence
|
2018
|
Hansheng Wang
Ying Zhang
Jun Shao
Shein‐Chung Chow
|
|
+
|
Good Statistics Practice (GSP)
|
2018
|
Shein‐Chung Chow
|
|
+
|
Seamless Adaptive Trial Design: Dose Selection Criteria
|
2018
|
Jiayin Zheng
Shein‐Chung Chow
|
|
+
|
Multivariate Normal and Related Distributions
|
2018
|
Song-Gui Wang
Shein‐Chung Chow
|
|
+
|
Statistical Design and Analysis in Pharmaceutical Science
|
2018
|
Shein‐Chung Chow
Jen‐pei Liu
|
|
+
|
On sample size requirement for analytical similarity assessment
|
2018
|
Yi Zhao
Yu‐Wei Chang
Shein‐Chung Chow
|
|
+
|
Adaptive Trial Design in Clinical Research
|
2018
|
Annpey Pong
Shein‐Chung Chow
|
|
+
|
Analysis of Two-Stage Adaptive Trial Designs
|
2018
|
Shein‐Chung Chow
Min Lin
|
|
+
|
Design and Analysis of Biosimilar Studies
|
2018
|
Shein‐Chung Chow
Fuyu Song
|
|
+
PDF
Chat
|
Statistical Methods for Conditional Survival Analysis
|
2017
|
Sin‐Ho Jung
Ho Yun Lee
Shein‐Chung Chow
|
|
+
|
On evaluation of consistency in multi-regional clinical trials
|
2017
|
Lisa Ying
Fuyu Song
Shein‐Chung Chow
Na Zeng
Jiayin Zheng
Xiaodong Li
David Henry
Venkat Sethuraman
|
|
+
|
Tests for Goodness-of-Fit and Contingency Tables
|
2017
|
Shein‐Chung Chow
Jun Shao
Hansheng Wang
Yuliya Lokhnygina
|
|
+
|
Sample Size Calculation in Other Areas
|
2017
|
Shein‐Chung Chow
Jun Shao
Hansheng Wang
Yuliya Lokhnygina
|
|
+
|
Large Sample Tests for Proportions
|
2017
|
Shein‐Chung Chow
Jun Shao
Hansheng Wang
Yuliya Lokhnygina
|
|
+
|
Considerations Prior to Sample Size Calculation
|
2017
|
Shein‐Chung Chow
Jun Shao
Hansheng Wang
Yuliya Lokhnygina
|
|
+
|
Sample Size for Clinical Trials with Extremely Low Incidence Rate
|
2017
|
Shein‐Chung Chow
Jun Shao
Hansheng Wang
Yuliya Lokhnygina
|
|
+
|
Sample Size Calculation for Two-Stage Adaptive Trial Design
|
2017
|
Shein‐Chung Chow
Jun Shao
Hansheng Wang
Yuliya Lokhnygina
|
|
+
|
Sample Size Calculations for Cluster Randomized Trials
|
2017
|
Shein‐Chung Chow
Jun Shao
Hansheng Wang
Yuliya Lokhnygina
|
|
+
|
Sample Size Calculations in Clinical Research: Third Edition
|
2017
|
Shein‐Chung Chow
Jun Shao
Hansheng Wang
Yuliya Lokhnygina
|
|
+
|
Bioequivalence Testing
|
2017
|
Shein‐Chung Chow
Jun Shao
Hansheng Wang
Yuliya Lokhnygina
|
|
+
|
Bayesian Sample Size Calculation
|
2017
|
Shein‐Chung Chow
Jun Shao
Hansheng Wang
Yuliya Lokhnygina
|
|
+
|
Test for Homogeneity of Two Zero-Inflated Poisson Population
|
2017
|
Shein‐Chung Chow
Jun Shao
Hansheng Wang
Yuliya Lokhnygina
|
|
+
|
Analytical similarity assessment
|
2017
|
Shein‐Chung Chow
Fuyu Song
|
|
+
|
Quantitative Methods for Clinical Trials and Epidemiology
|
2017
|
Cliburn Chan
Michael G. Hudgens
Shein‐Chung Chow
|
|
+
|
Adaptive Clinical Trial Design
|
2017
|
Shein‐Chung Chow
Fuyu Song
|
|
+
|
On assessing bioequivalence and interchangeability between generics based on indirect comparisons
|
2017
|
Jiayin Zheng
Shein‐Chung Chow
Mengdie Yuan
|
|
+
|
Design and Analysis of Studies for Assessing Interchangeability
|
2017
|
Shein‐Chung Chow
László Endrényi
|
|
+
|
Statistical Methods for Assessing Biosimilarity
|
2017
|
Shein‐Chung Chow
Fuyu Song
|
|
+
|
On the establishment of equivalence acceptance criterion in analytical similarity assessment
|
2017
|
Tongrong Wang
Shein‐Chung Chow
|
|
+
|
On hybrid parallel–crossover designs for assessing drug interchangeability of biosimilar products
|
2016
|
Shein‐Chung Chow
Fuyu Song
Can Cui
|
|
+
|
Statistical evaluation of the scaled criterion for drug interchangeability
|
2016
|
Jianghao Li
Shein‐Chung Chow
|
|
+
|
Assessing bioequivalence and drug interchangeability
|
2016
|
Meng Chen
Shein‐Chung Chow
|
|
+
|
Sample size requirement in analytical studies for similarity assessment
|
2016
|
Shein‐Chung Chow
Fuyu Song
He Bai
|
|
+
|
On safety margin for drug interchangeability
|
2016
|
Jiayin Zheng
Shein‐Chung Chow
Fuyu Song
|
|
+
|
On the evaluation of reliability, repeatability, and reproducibility of instrumental evaluation methods and measurement systems
|
2016
|
Samir Salah
Shein‐Chung Chow
Fuyu Song
|
|
+
|
Seamless Adaptive Trial Designs
|
2016
|
Shein‐Chung Chow
|
|
+
PDF
Chat
|
Analytical Similarity Assessment in Biosimilar Studies
|
2016
|
Shein‐Chung Chow
Fuyu Song
He Bai
|
|
+
|
On sample size estimation and re-estimation adjusting for variability in confirmatory trials
|
2015
|
Pei-Shien Wu
Min Lin
Shein‐Chung Chow
|
|
+
PDF
Chat
|
Bioavailability and Bioequivalence
|
2015
|
Shein‐Chung Chow
|
|
+
|
Some thoughts on drug interchangeability
|
2015
|
Shein‐Chung Chow
Fuyu Song
Meng Chen
|
|
+
PDF
Chat
|
Intraarterial Microdosing: A Novel Drug Development Approach, Proof-of-Concept PET Study in Rats
|
2015
|
Tal Burt
Douglas Rouse
Kihak Lee
Huali Wu
Anita T. Layton
Thomas C. Hawk
Douglas H. Weitzel
Bennett B. Chin
Michael Cohen‐Wolkowiez
Shein‐Chung Chow
|
|
+
|
STATISTICS IN BIOPHARMACEUTICAL RESEARCH AND DEVELOPMENT
|
2015
|
Shein‐Chung Chow
Annpey Pong
|
|
+
PDF
Chat
|
Challenging issues in assessing analytical similarity in biosimilar studies
|
2015
|
Shein‐Chung Chow
|
|
+
PDF
Chat
|
On controversial statistical issues in clinical research
|
2015
|
Shein‐Chung Chow
Fuyu Song
|
|
+
PDF
Chat
|
Confidence Region Approach for Assessing Bioequivalence and Biosimilarity Accounting for Heterogeneity of Variability
|
2015
|
Jianghao Li
Shein‐Chung Chow
|
|
+
|
Minimum Therapeutically Effective Dose
|
2014
|
Jen‐pei Liu
Shein‐Chung Chow
|
|
+
|
Median Effective Dose
|
2014
|
Jen‐pei Liu
Shein‐Chung Chow
|
|
+
|
Sample Size Calculation for Comparing Variabilities
|
2014
|
Hansheng Wang
Shein‐Chung Chow
|
|
+
|
Sample Size Calculation for Comparing Proportions
|
2014
|
Hansheng Wang
Shein‐Chung Chow
|
|
+
|
Sample Size Calculation for Comparing Time‐to‐Event Data
|
2014
|
Hansheng Wang
Shein‐Chung Chow
|
|
+
PDF
Chat
|
Bioavailability and Bioequivalence
|
2014
|
Shein‐Chung Chow
|
|
+
|
Scientific Factors and Current Issues in Biosimilar Studies
|
2014
|
Shein‐Chung Chow
László Endrényi
Peter A. Lachenbruch
France Mentré
|
|
+
|
Frequency Estimator for Assessing of Follow-On Biologics
|
2014
|
Ying Lü
Zhongzhan Zhang
Shein‐Chung Chow
|
|
+
|
Nonparametric Tests for Evaluation of Biosimilarity in Variability of Follow-on Biologics
|
2014
|
Nan Zhang
Jun Yang
Shein‐Chung Chow
Eric Chi
|
|
+
|
Applications of the Bayesian Prior Information to Evaluation of Equivalence of Similar Biological Medicinal Products
|
2014
|
Shih‐Ting Chiu
Jen‐pei Liu
Shein‐Chung Chow
|
|
+
PDF
Chat
|
Bioavailability and bioequivalence in drug development
|
2014
|
Shein‐Chung Chow
|
|
+
|
On Statistical Tests for Homogeneity of Two Bivariate Zero-Inflated Poisson Populations
|
2014
|
Hak-Keung Yuen
Shein‐Chung Chow
Siu‐Keung Tse
|
|
+
PDF
Chat
|
Independent data monitoring committees: Preparing a path for the future
|
2014
|
Connie N. Hess
Matthew T. Roe
C. Michael Gibson
Robert J. Temple
Michael Pencina
Deborah A. Zarin
Kevin J. Anstrom
John H. Alexander
Rachel E. Sherman
Fred T. Fiedorek
|
|
+
|
Sample Size for Comparing Time‐to‐Event Data
|
2014
|
Hansheng Wang
Shein‐Chung Chow
|
|
+
|
Sample Size Estimation of Multiregional Clinical Trials with Heterogeneous Variability Across Regions
|
2014
|
Yuh‐Jenn Wu
Te-Sheng Tan
Shein‐Chung Chow
Chin‐Fu Hsiao
|
|
+
PDF
Chat
|
Adaptive Clinical Trial Design
|
2014
|
Shein‐Chung Chow
|
|
+
|
Statistical Designs for Pharmaceutical/Clinical Development
|
2014
|
Shein‐Chung Chow
|
|
+
PDF
Chat
|
Establishment of reference standards in biosimilar studies
|
2013
|
Aijing Zhang
Jung-Ying Tzeng
Shein‐Chung Chow
|
|
+
|
Design and Analysis of Clinical Trials: Concepts and Methodologies
|
2013
|
Shein‐Chung Chow
Jen‐pei Liu
|
|
+
|
Censored Data and Interim Analysis
|
2013
|
Shein‐Chung Chow
Jen‐pei Liu
|
|
+
|
Basic Design Considerations
|
2013
|
Shein‐Chung Chow
Jen‐pei Liu
|
|
+
|
Basic Statistical Concepts
|
2013
|
Shein‐Chung Chow
Jen‐pei Liu
|
|
+
|
Classification of Clinical Trials
|
2013
|
Shein‐Chung Chow
Jen‐pei Liu
|
|
+
|
Data Management of a Clinical Trial
|
2013
|
Shein‐Chung Chow
Jen‐pei Liu
|
|
+
|
Designs for Cancer Clinical Trials
|
2013
|
Shein‐Chung Chow
Jen‐pei Liu
|
|
+
|
Trials for Evaluating Accuracy of Diagnostic Devices
|
2013
|
Shein‐Chung Chow
Jen‐pei Liu
|
|
+
|
Biomarkers and Targeted Clinical Trials
|
2013
|
Shein‐Chung Chow
Jen‐pei Liu
|
|
+
|
Preparation and Implementation of a Clinical Protocol
|
2013
|
Shein‐Chung Chow
Jen‐pei Liu
|
|
+
|
Design and Analysis of Clinical Trials
|
2013
|
Shein‐Chung Chow
Jen‐Pei Liu
|
|
+
PDF
Chat
|
Wiley Series in Probability and Statistics
|
2013
|
Shein‐Chung Chow
Jen‐pei Liu
|
|
+
PDF
Chat
|
References
|
2013
|
Shein‐Chung Chow
Jen‐pei Liu
|
|
+
|
Index
|
2013
|
Shein‐Chung Chow
Jen‐pei Liu
|
|
+
|
Appendix A
|
2013
|
Shein‐Chung Chow
Jen‐pei Liu
|
|
+
|
Safety Assessment
|
2013
|
Shein‐Chung Chow
Jen‐pei Liu
|
|
+
|
Data Monitoring Committees in adaptive clinical trials
|
2013
|
Min Lin
Shein‐Chung Chow
|
|
+
|
Sample Size and Data Monitoring for Clinical Trials With Extremely Low Incidence Rates
|
2013
|
Shein‐Chung Chow
Shih‐Ting Chiu
|
|
+
|
Assessing biosimilarity and interchangeability of biosimilar products
|
2013
|
Shein‐Chung Chow
|
|
+
PDF
Chat
|
Assessing biosimilarity and interchangeability of biosimilar products under the Biologics Price Competition and Innovation Act
|
2013
|
Shein‐Chung Chow
|
|
+
|
Use of Random Effect Models in the Design and Analysis of Multi-regional Clinical Trials
|
2013
|
Yuh‐Jenn Wu
Te-Sheng Tan
Shein‐Chung Chow
Chin‐Fu Hsiao
|
|
+
|
Sample-Size Determination
|
2013
|
Shein‐Chung Chow
Jen‐pei Liu
|
|
+
|
Statistical Considerations in Biosimilar Assessment Using Biosimilarity Index
|
2013
|
Aijing Zhang
Jung-Ying Tzeng
Shein‐Chung Chow
|
|
+
|
Statistical assessment of biosimilarity based on relative distance between follow‐on biologics
|
2012
|
Seung‐Ho Kang
Shein‐Chung Chow
|
|
+
|
Statistical Methods for Bridging Studies
|
2012
|
Shein‐Chung Chow
Chieh Chiang
Jen‐pei Liu
Chin‐Fu Hsiao
|
|
+
|
An adapted <i>F</i>‐test for homogeneity of variability in follow‐on biological products
|
2012
|
Jun Yang
Nan Zhang
Shein‐Chung Chow
Eric Chi
|
|
+
|
Impact of variability on the choice of biosimilarity limits in assessing follow‐on biologics
|
2012
|
Nan Zhang
Jun Yang
Shein‐Chung Chow
László Endrényi
Eric Chi
|
|
+
|
Scientific considerations for assessing biosimilar products
|
2012
|
Shein‐Chung Chow
Jun Wang
László Endrényi
Peter A. Lachenbruch
|
|
+
|
On the interchangeability of biologic drug products
|
2012
|
László Endrényi
Chang Chiann
Shein‐Chung Chow
László Tóthfalusi
|
|
+
|
Application of the parallel line assay to assessment of biosimilar products based on binary endpoints
|
2012
|
Jr‐Rung Lin
Shein‐Chung Chow
Chih‐Hsi Chang
Ya‐Ching Lin
Jen‐pei Liu
|
|
+
|
Comments on the FDA draft guidance on biosimilar products
|
2012
|
Shein‐Chung Chow
László Endrényi
Peter A. Lachenbruch
|
|
+
|
The evaluation of biosimilarity index based on reproducibility probability for assessing follow‐on biologics
|
2012
|
Tsung‐Cheng Hsieh
Shein‐Chung Chow
Lan‐Yan Yang
Eric Chi
|
|
+
|
Statistical methods for assessing interchangeability of biosimilars
|
2012
|
Shein‐Chung Chow
Lan‐Yan Yang
Aijing Starr
Shih‐Ting Chiu
|
|
+
|
Analysis of Time-to-Event Data with Nonuniform Patient Entry and Loss to Follow-Up under a Two-Stage Seamless Adaptive Design with Weibull Distribution
|
2012
|
Qingshu Lu
Siu‐Keung Tse
Shein‐Chung Chow
Min Lin
|
|
+
|
On the Independence of Data Monitoring Committee in Adaptive Design Clinical Trials
|
2012
|
Shein‐Chung Chow
Ralph Corey
Min Lin
|
|
+
PDF
Chat
|
On Sample Size Calculation for Comparing Survival Curves Under General Hypothesis Testing
|
2012
|
Sin‐Ho Jung
Shein‐Chung Chow
|
|
+
|
Flexible, Adaptive or Attractive Clinical Trial Design
|
2012
|
Shein‐Chung Chow
|
|
+
|
Adaptive Design Methods in Clinical Trials
|
2011
|
Shein‐Chung Chow
Mark Chang
|
|
+
|
Controversial Statistical Issues in Clinical Trials
|
2011
|
Shein‐Chung Chow
|
|
+
PDF
Chat
|
Scientific factors for assessing biosimilarity and drug interchangeability of follow-on biologics
|
2011
|
Lan‐Yan Yang
Shein‐Chung Chow
László Endrényi
Lachenbruch
Чи
|
|
+
|
Sample size calculations for clinical trials
|
2011
|
Shein‐Chung Chow
|
|
+
|
Some Controversial Issues in Clinical Trials
|
2011
|
Shein‐Chung Chow
Lan‐Yan Yang
Ying Lu
|
|
+
|
Imputation Method Adjusted for Covariates for Nonrespondents in Instruments with Applications
|
2011
|
Juan Li
M. Eric
Chunyao. Feng
Shein‐Chung Chow
|
|
+
PDF
Chat
|
Benefits, challenges and obstacles of adaptive clinical trial designs
|
2011
|
Shein‐Chung Chow
Ralph Corey
|
|
+
|
Quantitative evaluation of Bioequivalence/ Biosimilarity
|
2011
|
Shein‐Chung Chow
|
|
+
|
Handbook of Adaptive Designs in Pharmaceutical and Clinical Development
|
2010
|
Annpey Pong
Shein‐Chung Chow
|
|
+
|
Bridging Diversity
|
2010
|
Shein‐Chung Chow
Chin‐Fu Hsiao
|
|
+
|
Assessing departure from dose linearity under a repeated measures incomplete block design
|
2010
|
Bin Cheng
Shein‐Chung Chow
|
|
+
|
On Flexibility of Adaptive Designs and Criteria for Choosing A Good One—A Discussion of FDA Draft Guidance
|
2010
|
Bin Cheng
Shein‐Chung Chow
|
|
+
|
A Note on Special Articles on Adaptive Clinical Trial Designs
|
2010
|
Shein‐Chung Chow
|
|
+
|
Clinical Strategy for Study Endpoint Selection
|
2010
|
Siu‐Keung Tse
Shein‐Chung Chow
Qingshu Lu
|
|
+
|
Sample Size Estimation/Allocation for Two-Stage Seamless Adaptive Trial Designs
|
2010
|
Shein‐Chung Chow
Annpey Pong
|
|
+
|
The Impact of Protocol Amendments in Adaptive Trial Designs
|
2010
|
Shein‐Chung Chow
Annpey Pong
|
|
+
|
Overview of Adaptive Design Methods in Clinical Trials
|
2010
|
Annpey Pong
Shein‐Chung Chow
|
|
+
|
Proposals of statistical consideration to evaluation of results for a specific region in multi‐regional trials – Asian perspective
|
2010
|
Hsiao‐Hui Tsou
Shein‐Chung Chow
K. K. Gordon Lan
Jen‐pei Liu
Mey Wang
Herng‐Der Chern
Low‐Tone Ho
Chao A. Hsiung
Chin‐Fu Hsiao
|
|
+
|
Reproducibility Probability in Clinical Research
|
2010
|
Shein‐Chung Chow
|
|
+
|
Analysis of Time-to-Event Data Under a Two-Stage Survival Adaptive Design in Clinical Trials
|
2010
|
Qingshu Lu
Siu‐Keung Tse
Shein‐Chung Chow
|
|
+
|
Adaptive Design Methods in Clinical Trials
|
2010
|
Shein‐Chung Chow
Mark Chang
|
|
+
|
Imputation in Clinical Research
|
2010
|
Hansheng Wang
Shein‐Chung Chow
|
|
+
|
Test for Ordered Categorical Data
|
2010
|
Shein‐Chung Chow
Siu‐Keung Tse
Chunyan Yang
|
|
+
|
Biosimilarity of Follow-On Biologics
|
2010
|
Shein‐Chung Chow
Jen‐pei Liu
|
|
+
|
Randomization
|
2010
|
Shein‐Chung Chow
Jun Shao
|
|
+
|
Validity of LOCF
|
2010
|
Bin Cheng
Shein‐Chung Chow
|
|
+
|
Calibration
|
2010
|
Shein‐Chung Chow
|
|
+
|
Translational Medicine: Concepts, Statistical Methods, and Related Issues
|
2010
|
Siu‐Keung Tse
Shein‐Chung Chow
|
|
+
|
Comparing Variabilities in Clinical Research
|
2010
|
Yonghee Lee
Hansheng Wang
Shein‐Chung Chow
|
|
+
|
Good Statistics Practice
|
2010
|
Shein‐Chung Chow
|
|
+
|
<i>In Vitro</i>Bioequivalence Testing
|
2010
|
Hansheng Wang
Ying Zhang
Jun Shao
Shein‐Chung Chow
|
|
+
|
Slope Approach for Assessment of Dose Proportionality/Linearity Under a Crossover Design
|
2010
|
Bin Cheng
Shein‐Chung Chow
|
|
+
|
Individual Bioequivalence
|
2010
|
Shein‐Chung Chow
Jen‐pei Liu
|
|
+
|
Generalizability Probability in Clinical Research
|
2010
|
Shein‐Chung Chow
|
|
+
|
Reproducibility Probability in Clinical Research
|
2010
|
Shein‐Chung Chow
|
|
+
|
Bayesian Approach for Analysis of Binary Responses in Clinical Trials with Protocol Amendments
|
2010
|
L.‐C. Yang
Shein‐Chung Chow
Yunchan Chi
|
|
+
|
Statistical Methods for Assessment of Biosimilarity Using Biomarker Data
|
2009
|
Shein‐Chung Chow
Qingshu Lu
Siu‐Keung Tse
Eric Chi
|
|
+
|
Statistical Test for Evaluation of Biosimilarity in Variability of Follow-On Biologics
|
2009
|
Tsung‐Cheng Hsieh
Shein‐Chung Chow
Jen‐pei Liu
Chin‐Fu Hsiao
Eric Chi
|
|
+
|
A Comparison of Moment-Based and Probability-Based Criteria for Assessment of Follow-On Biologics
|
2009
|
Shein‐Chung Chow
Tsung‐Cheng Hsieh
Eric Chi
Jun Yang
|
|
+
|
On Assessing Bioequivalence Using Genomic Data with Model Misspecification
|
2009
|
Qingshu Lu
Siu‐Keung Tse
Shein‐Chung Chow
Jun Yang
|
|
+
|
Deviations from linearity in statistical evaluation of linearity in assay validation
|
2009
|
Jen‐pei Liu
Shein‐Chung Chow
Tsung‐Cheng Hsieh
|
|
+
|
Statistical Methods in Translational Medicine
|
2008
|
Shein‐Chung Chow
Siu‐Keung Tse
Dennis Cosmatos
|
|
+
|
Statistical Methods in Translational Medicine
|
2008
|
Shein‐Chung Chow
Siu‐Keung Tse
Min Lin
|
|
+
|
Statistical Test for Ordered Categorical Data in Clinical Trials
|
2008
|
Shein‐Chung Chow
Siu‐Keung Tse
Chunyan Yang
Dennis Cosmatos
Eric Chi
|
|
+
|
Assessment of Bioequivalence for More Than Two Formulations
|
2008
|
Shein‐Chung Chow
Jen‐pei Liu
|
|
+
|
Assumptions of Outlier Detection for Average Bioequivalence
|
2008
|
Shein‐Chung Chow
Jen‐pei Liu
|
|
+
|
Statistical Methods for Average Bioequivalence
|
2008
|
Shein‐Chung Chow
Jen‐pei Liu
|
|
+
|
Optimal Crossover Designs for Two Formulations for Average Bioequivalence
|
2008
|
Shein‐Chung Chow
Jen‐pei Liu
|
|
+
|
Statistical Procedures for Assessment of Population and Individual Bioequivalence
|
2008
|
Shein‐Chung Chow
Jen‐pei Liu
|
|
+
|
Population and Individual Bioequivalence
|
2008
|
Shein‐Chung Chow
Jen‐pei Liu
|
|
+
|
Design of Bioavailability Studies
|
2008
|
Shein‐Chung Chow
Jen‐pei Liu
|
|
+
|
Design and Analysis of Bioavailability and Bioequivalence Studies
|
2008
|
Shein‐Chung Chow
Jen‐pei Liu
|
|
+
|
Design and Analysis of Bioavailability and Bioequivalence Studies, The Third Edition
|
2008
|
Shein‐Chung Chow
Jen‐pei Liu
|
|
+
|
On Power and Sample Size Calculation for QT Studies with Recording Replicates at Given Time Point
|
2008
|
Shein‐Chung Chow
Bin Cheng
Dennis Cosmatos
|
|
+
|
Statistical Assessment of QT/QTc Prolongation Based on Maximum of Correlated Normal Random Variables
|
2008
|
Bin Cheng
Shein‐Chung Chow
David Burt
Dennis Cosmatos
|
|
+
PDF
Chat
|
Adaptive design methods in clinical trials – a review
|
2008
|
Shein‐Chung Chow
Mark Chang
|
|
+
|
A Two-Stage Design for Drug Screening Trials Based on Continuous Endpoints
|
2008
|
Hsiao‐Hui Tsou
Chin‐Fu Hsiao
Shein‐Chung Chow
Jen‐pei Liu
|
|
+
|
Sample size calculation for the log-rank tests for multi-arm trials with a control
|
2008
|
Sin‐Ho Jung
Shein‐Chung Chow
Choongrak Kim
|
|
+
|
Statistical Issues on the Diagnostic Multivariate Index Assay for Targeted Clinical Trials
|
2007
|
Jen‐pei Liu
Shein‐Chung Chow
|
|
+
|
Statistical Analysis for Two-Stage Seamless Design with Different Study Endpoints
|
2007
|
Shein‐Chung Chow
Qingshu Lu
Siu‐Keung Tse
|
|
+
|
Adaptive Group Sequential Test for Clinical Trials with Changing Patient Population
|
2007
|
Huaibao Feng
Jun Shao
Shein‐Chung Chow
|
|
+
|
Analysis Strategies for Adaptive Designs with Multiple Endpoints
|
2007
|
Mark Chang
Shein‐Chung Chow
|
|
+
|
Bioequivalence Studies in Drug Development, Methods and Applications by D. HAUSCHKE, V. STEINIJANS, and I. PIGEOT
|
2007
|
Shein‐Chung Chow
|
|
+
|
Bayesian Sample Size Calculation
|
2007
|
Shein‐Chung Chow
Jun Shao
Hansheng Wang
Yuliya Lokhnygina
|
|
+
|
Sample Size Calculations in Clinical Research, Second Edition
|
2007
|
Jun Shao
Shein‐Chung Chow
Hansheng Wang
|
|
+
|
Sample Size Calculations in Clinical Research
|
2007
|
Shein‐Chung Chow
Hansheng Wang
Jun Shao
|
|
+
|
Mixed Noninferiority Margin and Statistical Tests in Active Controlled Trials
|
2007
|
Hsiao‐Hui Tsou
Chin‐Fu Hsiao
Shein‐Chung Chow
Lilly Q. Yue
Yunling Xu
Shiowjen Lee
|
|
+
|
Power and Sample Size for Dose Response Studies
|
2006
|
Mark Chang
Shein‐Chung Chow
|
|
+
|
A Note on Sample Size Calculation Based on Propensity Analysis in Nonrandomized Trials
|
2006
|
Sin‐Ho Jung
Shein‐Chung Chow
M. Eric
|
|
+
|
Adaptive Design Methods in Clinical Trials
|
2006
|
Shein‐Chung Chow
Mark Chang
|
|
+
|
Sample Size Calculation for Comparing Time‐to‐Event Data
|
2006
|
Hansheng Wang
Shein‐Chung Chow
|
|
+
|
Sample Size Calculation for Comparing Proportions
|
2006
|
Hansheng Wang
Shein‐Chung Chow
|
|
+
|
Sample Size Calculation for Comparing Variabilities
|
2006
|
Hansheng Wang
Shein‐Chung Chow
|
|
+
|
Adaptive Design in Clinical Research: Issues, Opportunities, and Recommendations
|
2006
|
Mark Chang
Shein‐Chung Chow
Annpey Pong
|
|
+
|
On the Assessment of Dose Proportionality: A Comparison of Two Slope Approaches
|
2006
|
Bin Cheng
Shein‐Chung Chow
Wei‐Lun Su
|
|
+
|
On non-inferiority margin and statistical tests in active control trials
|
2005
|
Shein‐Chung Chow
Jun Shao
|
|
+
|
Bioavailability and Bioequivalence
|
2005
|
Shein‐Chung Chow
|
|
+
|
Sample Size Calculation for Comparing Proportions
|
2005
|
Hansheng Wang
Shein‐Chung Chow
|
|
+
|
Sample Size Calculation for Comparing Time‐to‐Event Data
|
2005
|
Hansheng Wang
Shein‐Chung Chow
|
|
+
|
Sample Size Calculation for Comparing Means
|
2005
|
Hansheng Wang
Shein‐Chung Chow
|
|
+
|
Sample Size Calculation for Comparing Variabilities
|
2005
|
Hansheng Wang
Shein‐Chung Chow
|
|
+
|
A Bayesian Approach on Sample Size Calculation for Comparing Means
|
2005
|
Hansheng Wang
Shein‐Chung Chow
Murphy Chen
|
|
+
|
A Hybrid Bayesian Adaptive Design for Dose Response Trials
|
2005
|
Mark Chang
Shein‐Chung Chow
|
|
+
|
Statistical Consideration of Adaptive Methods in Clinical Development
|
2005
|
Shein‐Chung Chow
Mark Chang
Annpey Pong
|
|
+
|
Inference for Clinical Trials with Some Protocol Amendments
|
2005
|
Shein‐Chung Chow
Jun Shao
|
|
+
|
Minimum Therapeutically Effective Dose
|
2005
|
Jen‐pei Liu
Shein‐Chung Chow
|
|
+
|
Median Effective Dose
|
2005
|
Jen‐pei Liu
Shein‐Chung Chow
|
|
+
|
Authors' Reply
|
2005
|
Jun Shao
Shein‐Chung Chow
|
|
+
|
Statistical inference for cancer trials with treatment switching
|
2005
|
Jun Shao
Mark Chang
Shein‐Chung Chow
|
|
+
|
Assessing Bioequivalence Using Genomic Data
|
2004
|
Shein‐Chung Chow
Jun Shao
Li Li
|
|
+
|
Bioavailability and Bioequivalence
|
2004
|
Shein‐Chung Chow
|
|
+
|
Modified Large-Sample Confidence Intervals for Linear Combinations of Variance Components
|
2004
|
Yonghee Lee
Jun Shao
Shein‐Chung Chow
|
|
+
|
Inference in Case-Control Studies
|
2004
|
Gary King
Langche Zeng
Shein‐Chung Chow
|
|
+
|
Designs for Clinical Trials
|
2003
|
Shein‐Chung Chow
Jen‐pei Liu
|
|
+
|
Analysis of Categorical Data
|
2003
|
Shein‐Chung Chow
Jen‐pei Liu
|
|
+
|
Design and Analysis of Clinical Trials
|
2003
|
Shein‐Chung Chow
Jen‐pei Liu
|
|
+
|
Analysis of Continuous Data
|
2003
|
Shein‐Chung Chow
Jen‐pei Liu
|
|
+
|
Issues in Efficacy Evaluation
|
2003
|
Shein‐Chung Chow
Jen‐pei Liu
|
|
+
|
Censored Data and Interim Analysis
|
2003
|
Shein‐Chung Chow
Jen‐pei Liu
|
|
+
|
Preparation and Implementation of a Clinical Protocol
|
2003
|
Shein‐Chung Chow
Jen‐pei Liu
|
|
+
|
Wiley Series in Probability and Statistics
|
2003
|
Shein‐Chung Chow
Jen‐pei Liu
|
|
+
|
Bibliography
|
2003
|
Shein‐Chung Chow
Jen‐pei Liu
|
|
+
|
Designs for Cancer Clinical Trials
|
2003
|
Shein‐Chung Chow
Jen‐pei Liu
|
|
+
|
Classification of Clinical Trials
|
2003
|
Shein‐Chung Chow
Jen‐pei Liu
|
|
+
|
Basic Design Considerations
|
2003
|
Shein‐Chung Chow
Jen‐pei Liu
|
|
+
|
Basic Statistical Concepts
|
2003
|
Shein‐Chung Chow
Jen‐pei Liu
|
|
+
|
STATISTICS IN BIOPHARMACEUTICAL RESEARCH
|
2003
|
Shein‐Chung Chow
Annpey Pong
|
|
+
|
Sample Size Calculations in Clinical Research
|
2003
|
Shein‐Chung Chow
Hansheng Wang
Jun Shao
|
|
+
|
Sample Size Determination Based on Rank Tests in Clinical Trials
|
2003
|
Hansheng Wang
Bin Chen
Shein‐Chung Chow
|
|
+
|
Stability Analysis with Discrete Responses
|
2003
|
Shein‐Chung Chow
Jun Shao
|
|
+
|
Examining Outlying Subjects and Outlying Records in Bioequivalence Trials
|
2003
|
Wenping Wang
Shein‐Chung Chow
|
|
+
|
STATISTICAL TESTS FOR POPULATION BIOEQUIVALENCE
|
2003
|
Shein‐Chung Chow
Jun Shao
Hansheng Wang
|
|
+
|
Imputation in Clinical Research
|
2003
|
Hansheng Wang
Shein‐Chung Chow
|
|
+
|
<i>In vitro</i> bioequivalence testing
|
2002
|
Shein‐Chung Chow
Jun Shao
Hansheng Wang
|
|
+
|
A practical approach for comparing means of two groups without equal variance assumption
|
2002
|
Hansheng Wang
Shein‐Chung Chow
|
|
+
|
A note on statistical methods for assessing therapeutic equivalence
|
2002
|
Shein‐Chung Chow
Jun Shao
|
|
+
|
Reproducibility probability in clinical trials
|
2002
|
Jun Shao
Shein‐Chung Chow
|
|
+
|
Bioavailability and Bioequivalence
|
2002
|
Shein‐Chung Chow
|
|
+
|
Statistics in Drug Research
|
2002
|
Shein‐Chung Chow
Jun Shao
|
|
+
|
Individual bioequivalence testing under 2×3 designs
|
2002
|
Shein‐Chung Chow
Jun Shao
Hansheng Wang
|
|
+
|
ON SAMPLE SIZE CALCULATION BASED ON ODDS RATIO IN CLINICAL TRIALS
|
2002
|
Hansheng Wang
Shein‐Chung Chow
Gang Li
|
|
+
|
TESTS FOR INTER-SUBJECT AND TOTAL VARIABILITIES UNDER CROSSOVER DESIGNS
|
2002
|
Yonghee Lee
Jun Shao
Shein‐Chung Chow
Hansheng Wang
|
|
+
|
A NOTE ON SAMPLE SIZE CALCULATION FOR MEAN COMPARISONS BASED ON NONCENTRAL <i>t</i>-STATISTICS
|
2002
|
Shein‐Chung Chow
Jun Shao
Hansheng Wang
|
|
+
|
Statistics in Drug Research: Methodologies and Recent Developments
|
2002
|
Shein‐Chung Chow
Jun Shao
|
|
+
|
BRIDGING STUDIES IN CLINICAL DEVELOPMENT
|
2002
|
Jen‐pei Liu
Shein‐Chung Chow
|
|
+
|
Probability lower bounds for USP/NF tests
|
2002
|
Shein‐Chung Chow
Jun Shao
Hansheng Wang
|
|
+
|
ON STATISTICAL POWER FOR AVERAGE BIOEQUIVALENCE TESTING UNDER REPLICATED CROSSOVER DESIGNS
|
2002
|
Hansheng Wang
Shein‐Chung Chow
|
|
+
|
On sample size calculation in bioequivalence trials.
|
2001
|
Shein‐Chung Chow
Hansheng Wang
|
|
+
|
DRUG SHELF-LIFE ESTIMATION
|
2001
|
Jun Shao
Shein‐Chung Chow
|
|
+
|
On statistical analysis for placebo-challenging designs in clinical trials
|
2000
|
Shein‐Chung Chow
Jun Shao
Hsin‐Tsung Ho
|
|
+
|
On statistical analysis for placebo‐challenging designs in clinical trials
|
2000
|
Shein‐Chung Chow
Jun Shao
Hsin‐Tsung Ho
|
|
+
|
BIOEQUIVALENCE REVIEW FOR DRUG INTERCHANGEABILITY
|
1999
|
Shein‐Chung Chow
Jun Shao
|
|
+
|
Individual Bioequivalence—A Review of the FDA Draft Guidance
|
1999
|
Shein‐Chung Chow
|
|
+
|
An Overview of the Regulatory Approval Process in Drug Development
|
1998
|
Shein‐Chung Chow
Annpey Pong
|
|
+
|
Design and Analysis of Multinational Clinical Trials
|
1998
|
Hsin‐Tsung Ho
Shein‐Chung Chow
|
|
+
|
Design and analysis of clinical trials : concept and methodologies
|
1998
|
Shein‐Chung Chow
Jen‐pei Liu
|
|
+
|
Good Statistics Practice in the Drug Development and Regulatory Approval Process
|
1997
|
Shein‐Chung Chow
|
|
+
|
Statistical/Practical Issues in Clinical Trials
|
1997
|
Annpey Pong
Shein‐Chung Chow
|
|
+
|
STATISTICAL METHODS FOR TWO-SEQUENCE THREE-PERIOD CROSS-OVER DESIGNS WITH INCOMPLETE DATA
|
1997
|
Shein‐Chung Chow
Jun Shao
|
|
+
|
A note on sample size determination for bioequivalence studies with high-order crossover designs.
|
1997
|
Keh-Wei Chen
Shein‐Chung Chow
Gang Li
|
|
+
|
A two one-sided tests procedure for assessment of individual bioequivalence
|
1997
|
Jen‐pei Liu
Shein‐Chung Chow
|
|
+
|
Guest editor's note: recent issues in bioequivalence trials
|
1997
|
Shein‐Chung Chow
|
|
+
|
Meta-analysis for bioequivalence review
|
1997
|
Shein‐Chung Chow
Jen‐pei Liu
|
|
+
|
An adjusted two one-sided <i>t</i>-test for the assessment of bioequivalence with multiple doses
|
1997
|
Wenping Wang
Francis Hsuan
Shein‐Chung Chow
|
|
+
|
Some thoughts on individual bioequivalence
|
1997
|
Jen‐pei Liu
Shein‐Chung Chow
|
|
+
|
A Note on sample Size Determination for
|
1997
|
Keh-Wei Chen
Shein‐Chung Chow
Gang Li
|
|
+
PDF
Chat
|
Statistical Issues on the FDA Conjugated Estrogen Tablets Bioequivalence Guidance
|
1996
|
Jen‐pei Liu
Shein‐Chung Chow
|
|
+
|
Statistical Design and Analysis in Pharmaceutical Science.
|
1996
|
Michael Hale
Russell L. Reeve
Carol Francisco
Shein‐Chung Chow
Jen‐pei Liu
|
|
+
PDF
Chat
|
THE IMPACT OF PATIENT COMPLIANCE ON DRUG CONCENTRATION PROFILE IN MULTIPLE DOSES
|
1996
|
Wen‐Ping Wang
FRANCIS HUSAN
Shein‐Chung Chow
|
|
+
|
Statistical Design and Analysis in Pharmaceutical Science
|
1996
|
Eric R. Ziegel
Shein‐Chung Chow
Jiewen Liu
|
|
+
|
Guest Editor's Note: Bioavailability and Bioequivalence
|
1995
|
Shein‐Chung Chow
|
|
+
|
Replicated Crossover Designs in Bioavailability and Bioequivalence Trials
|
1995
|
Jen‐pei Liu
Shein‐Chung Chow
|
|
+
|
Application of Williams' Design for Bioequivalence Trials
|
1995
|
Emmanuel Mohandoss
Shein‐Chung Chow
Fanny Y. C. Ki
|
|
+
|
Current Issues in Bioequivalence Trials
|
1995
|
Shein‐Chung Chow
Jen‐pei Liu
|
|
+
|
Current Issues in Regulatory Requirements of Drug Stability
|
1995
|
Shein‐Chung Chow
Annpey Pong
|
|
+
|
Statistical Justification for the Use of Composite Scores in Quality of Life Assessment
|
1995
|
Fanny Y. C. Ki
Shein‐Chung Chow
|
|
+
|
The impact of outlying subjects on decising of bioequivalence
|
1995
|
Fanny Y. C. Ki
Jen‐pei Liu
Wenping Wang
Shein‐Chung Chow
|
|
+
|
On likelihood distance for outliers detection
|
1995
|
Wenping Wang
Shein‐Chung Chow
William W. S. Wei
|
|
+
|
On model selection for standard curve in assay development
|
1995
|
Siu‐Keung Tse
Shein‐Chung Chow
|
|
+
|
On stability designs in drug shelf-life estimation
|
1995
|
Huey L. Ju
Shein‐Chung Chow
|
|
+
|
Statistical Inference in Stability Analysis
|
1994
|
Jun Shao
Shein‐Chung Chow
|
|
+
|
Recent Statistical Developments in Bioequivalence Trials — A Review of the FDA Guidance*
|
1994
|
Shein‐Chung Chow
Jen‐pei Liu
|
|
+
|
On ordinary least-squares methods for sample surveys
|
1994
|
Song-Gui Wang
Shein‐Chung Chow
Siu‐Keung Tse
|
|
+
|
Statistical considerations in bioequivalence trials
|
1994
|
Shein‐Chung Chow
Jen‐pei Liu
|
|
+
|
On statistical characteristics of quality of life assessment
|
1994
|
Shein‐Chung Chow
Fanny Y. C. Ki
|
|
+
|
Constructing Release Targets for Drug Products: a Bayesian Decision Theory Approach
|
1993
|
Tom Fearn
Costas Goutis
Jun Shao
Shein‐Chung Chow
|
|
+
|
On Assessment of Bioequivalence for Drugs with Negligible Plasma Levels
|
1993
|
Jen‐pei Liu
Shein‐Chung Chow
|
|
+
|
Sample size determination for the two one-sided tests procedure in bioequivalence
|
1992
|
Jen‐pei Liu
Shein‐Chung Chow
|
|
+
|
On assessment of bioequivalence under a higher-order crossover design
|
1992
|
Shein‐Chung Chow
Jen‐pei Liu
|
|
+
|
On the assessment of variability in bioavailability/bioequivalence studies
|
1992
|
Jen‐pei Liu
Shein‐Chung Chow
|
|
+
|
Test for batch‐to‐batch variation in stability analysis
|
1992
|
Costas Goutis
Tom Fearn
Shein‐Chung Chow
Jun Shao
|
|
+
|
The estimation of parameters from bulked samples
|
1991
|
Shein‐Chung Chow
Erik V. Nordheim
|
|
+
|
Assessment of bioequivalence using a multiplicative model
|
1991
|
Shein‐Chung Chow
Karl E. Peace
Jun Shao
|
|
+
|
Alternative Approaches for Assessing Bioequivalence regarding Normality Assumptions
|
1990
|
Shein‐Chung Chow
|
|
+
|
A note on adaptive generalized ridge regression estimator
|
1990
|
Song-Gui Wang
Shein‐Chung Chow
|
|
+
|
On the measures of multicollinearity in least squares regression
|
1990
|
Song-Gui Wang
Siu‐Keung Tse
Shein‐Chung Chow
|
|
+
|
TEST FOR TREATMENT EFFECT BASED ON BINARY DATA WITH RANDOM SAMPLE SIZES
|
1990
|
Jun Shao
Shein‐Chung Chow
|
|
+
|
An Alternative Approach for the Assessment of Bioequivalence Between Two Formulations of a Drug
|
1990
|
Shein‐Chung Chow
Jun Shao
|
|
+
|
A Related Problem in Bioavailability/Bioequivalence Studies — Estimation of the Intrasubject Variability With a Common CV
|
1990
|
Shein‐Chung Chow
Siu‐Keung Tse
|
|
+
|
On the Difference Between the Classical and Inverse Methods of Calibration
|
1990
|
Shein‐Chung Chow
Jun Shao
|
|
+
|
A new procedure for the estimation of variance components
|
1988
|
Shein‐Chung Chow
Jun Shao
|
|
+
|
some results on cononical correlations and measures of multivariate association
|
1987
|
Song-Gui Wang
Shein‐Chung Chow
|